Najnovšie poklady

The promise of Low Dose Naltrexone Therapy

9,50 €

toto ma zaujíma

Naltrexone is an opiate antagonist drug developed in the 1970s and approved by the FDA in 1984 for opiate and drug abuse treatment. When used at much lower doses in an off-label protocol referred to as low dose naltrexone (LDN), the drug has been shown to halt disease progression in Crohn's disease and certain cancers, to reduce symptoms in multiple sclerosis and autism

Rok vydania 2009
Vydavateľstvo McFarland
Jazyk anglický
Väzba mäkká
Počet strán 213
Prebal nie
Stav Ako nová
Umiestnenie 39/6

30 ďalších produktov v rovnakej kategórii: